ORIC Pharmaceuticals, Inc.
ORIC
$8.60
-$0.23-2.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 33.29M | 33.19M | 32.09M | 31.31M | 29.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 149.91M | 143.00M | 148.02M | 149.67M | 146.62M |
| Operating Income | -149.91M | -143.00M | -148.02M | -149.67M | -146.62M |
| Income Before Tax | -135.21M | -129.47M | -135.27M | -137.25M | -132.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -135.21 | -129.47 | -135.27 | -137.25 | -132.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -135.21M | -129.47M | -135.27M | -137.25M | -132.86M |
| EBIT | -149.91M | -143.00M | -148.02M | -149.67M | -146.62M |
| EBITDA | -148.72M | -141.78M | -146.82M | -148.48M | -145.48M |
| EPS Basic | -1.43 | -1.51 | -1.73 | -1.89 | -1.88 |
| Normalized Basic EPS | -0.89 | -0.95 | -1.08 | -1.18 | -1.18 |
| EPS Diluted | -1.43 | -1.51 | -1.73 | -1.89 | -1.88 |
| Normalized Diluted EPS | -0.89 | -0.95 | -1.08 | -1.18 | -1.18 |
| Average Basic Shares Outstanding | 385.14M | 350.71M | 318.77M | 290.36M | 282.58M |
| Average Diluted Shares Outstanding | 385.14M | 350.71M | 318.77M | 290.36M | 282.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |